Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
23,917.01
25,114.03
23,177.75
21,307.95
19,193.10
16,738.17
18,083.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
23,917.01
25,114.03
23,177.75
21,307.95
19,193.10
16,738.17
18,083.19
Raw Material Cost
11,177.18
10,906.06
9,775.73
8,665.62
7,445.35
6,532.86
6,523.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
200.79
75.35
41.34
27.54
37.09
49.65
86.76
Selling and Distribution Expenses
11,300.70
11,529.58
10,631.98
9,807.72
8,442.04
7,431.55
8,319.49
Other Expenses
66.42
88.46
83.31
63.54
44.85
41.70
38.39
Total Expenditure (Excl Depreciation)
23,342.82
23,395.63
21,282.13
19,136.28
16,372.95
14,431.09
15,313.83
Operating Profit (PBDIT) excl Other Income
574.2
1718.4
1895.6
2171.7
2820.1
2307.1
2769.4
Other Income
128.09
-44.58
86.78
-22.62
-120.30
-30.91
-11.42
Operating Profit (PBDIT)
2,316.14
3,182.80
3,428.88
3,551.86
3,962.01
3,526.86
4,021.70
Interest
200.79
75.35
41.34
27.54
37.09
49.65
86.76
Exceptional Items
-7.88
-1,778.41
-155.57
-204.71
245.66
-54.01
69.42
Gross Profit (PBDT)
12,739.83
14,207.98
13,402.02
12,642.33
11,747.75
10,205.32
11,559.48
Depreciation
1,613.86
1,671.44
1,595.18
1,549.81
1,420.78
1,388.83
1,388.58
Profit Before Tax
493.61
-342.40
1,636.79
1,769.80
2,749.80
2,034.37
2,615.78
Tax
218.70
126.66
331.30
334.07
608.10
353.63
428.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
263.14
-461.80
1,271.68
1,423.72
2,135.69
1,664.52
2,164.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
263.14
-461.80
1,271.68
1,423.72
2,135.69
1,664.52
2,164.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
11.77
-7.26
33.81
12.01
6.01
16.23
22.52
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
274.91
-469.06
1,305.49
1,435.73
2,141.71
1,680.74
2,187.47
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
25,399.96
24,679.26
25,511.32
23,161.63
21,386.44
18,628.77
16,928.30
Earnings per share (EPS)
9.99
-17.54
48.31
54.03
80.95
63.09
82.02
Diluted Earnings per share
9.99
-17.54
48.31
54.03
80.95
63.09
82.02
Operating Profit Margin (Excl OI)
2.4%
6.2%
7.54%
9.5%
13.87%
12.96%
14.62%
Gross Profit Margin
8.81%
5.29%
13.94%
15.58%
21.73%
20.45%
22.14%
PAT Margin
1.1%
-1.84%
5.49%
6.68%
11.13%
9.94%
11.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -4.77% vs 8.35% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 158.60% vs -135.93% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -32.21% vs -3.43% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 166.67% vs 82.32% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Japan Medical Dynamic Marketing, Inc. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
23,917.01
2,978.63
20,938.38
702.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
23,917.01
2,978.63
20,938.38
702.95%
Raw Material Cost
11,177.18
1,347.99
9,829.19
729.17%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
200.79
0.00
200.79
Selling and Distribution Expenses
11,300.70
1,224.26
10,076.44
823.06%
Other Expenses
66.42
53.68
12.74
23.73%
Total Expenditure (Excl Depreciation)
23,342.82
3,109.04
20,233.78
650.80%
Operating Profit (PBDIT) excl Other Income
574.18
-130.41
704.59
540.29%
Other Income
128.09
175.46
-47.37
-27.00%
Operating Profit (PBDIT)
2,316.14
95.76
2,220.38
2,318.69%
Interest
200.79
0.00
200.79
Exceptional Items
-7.88
0.00
-7.88
Gross Profit (PBDT)
12,739.83
1,630.63
11,109.20
681.28%
Depreciation
1,613.86
50.70
1,563.16
3,083.16%
Profit Before Tax
493.61
45.05
448.56
995.69%
Tax
218.70
-58.19
276.89
475.84%
Provisions and contingencies
0
0
0.00
Profit After Tax
263.14
103.25
159.89
154.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
263.14
103.25
159.89
154.86%
Share in Profit of Associates
0
0
0.00
Minority Interest
11.77
0.00
11.77
Other related items
0.00
0.00
0.00
Consolidated Net Profit
274.91
103.25
171.66
166.26%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
25,399.96
8,984.95
16,415.01
182.69%
Earnings per share (EPS)
9.99
1.11
8.88
800.00%
Diluted Earnings per share
9.99
1.11
8.88
800.00%
Operating Profit Margin (Excl OI)
2.40%
-4.38%
0.00
6.78%
Gross Profit Margin
8.81%
3.21%
0.00
5.60%
PAT Margin
1.10%
3.47%
0.00
-2.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,391.70 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -4.77% vs 8.35% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 27.49 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 158.60% vs -135.93% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 218.80 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -32.21% vs -3.43% in Mar 2025
Annual - Interest
Interest 20.08 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 166.67% vs 82.32% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.40%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025






